烟酸甲酯血管扩张药

C₇H₇NO₂

137.14

113951

MFCD00006388

329830933

NA.24

Methyl nicotinate is a potent vasodilatory drug capable of transdermal penetration. It is known to elicit distinctive erythema through the production of prostaglandin D2(PGD2) and beneficial for the treatment of respiratory, vascular and rheumatoid disorders.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Please find SDS provided by EDQM here..

Sales restrictions may apply.

synthetic

pharmaceutical primary standard

EP

solid

EDQM

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

204 ℃ (lit.)

42-44 ℃ (lit.)

pharmaceutical (small molecule)

neat

2-8℃

COC(=O)c1cccnc1

1S/C7H7NO2/c1-10-7(9)6-3-2-4-8-5-6/h2-5H,1H3

YNBADRVTZLEFNH-UHFFFAOYSA-N

Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

GHS07

Warning

H315 - H319 - H335

P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Respiratory system

11 - Combustible Solids

WGK 3